Roscovitine blocks leukocyte extravasation by inhibition of cyclin‐dependent kinases 5 and 9
BACKGROUND AND PURPOSE Roscovitine, a cyclin‐dependent kinase (CDK) inhibitor
that induces tumour cell death, is under evaluation as an anti‐cancer drug. By triggering …
that induces tumour cell death, is under evaluation as an anti‐cancer drug. By triggering …
[HTML][HTML] Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9
N Berberich, B Uhl, J Joore… - British Journal of …, 2011 - ncbi.nlm.nih.gov
BACKGROUND AND PURPOSE Roscovitine, a cyclin-dependent kinase (CDK) inhibitor
that induces tumour cell death, is under evaluation as an anti-cancer drug. By triggering …
that induces tumour cell death, is under evaluation as an anti-cancer drug. By triggering …
[引用][C] Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9
N BERBERICH, B UHL, J JOORE… - British journal of …, 2011 - pascal-francis.inist.fr
Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and
9 CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
9 CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9.
N Berberich, B Uhl, J Joore, UK Schmerwitz… - British Journal of …, 2011 - europepmc.org
Background and purpose Roscovitine, a cyclin-dependent kinase (CDK) inhibitor that
induces tumour cell death, is under evaluation as an anti-cancer drug. By triggering …
induces tumour cell death, is under evaluation as an anti-cancer drug. By triggering …
[引用][C] Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9
N Berberich, B Uhl, J Joore, UK Schmerwitz… - British Journal of …, 2011 - cir.nii.ac.jp
Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9
N Berberich, B Uhl, J Joore… - British journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Background and purpose Roscovitine, a cyclin-dependent kinase (CDK) inhibitor that
induces tumour cell death, is under evaluation as an anti-cancer drug. By triggering …
induces tumour cell death, is under evaluation as an anti-cancer drug. By triggering …
Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9.
N Berberich, B Uhl, J Joore, UK Schmerwitz… - British Journal of …, 2011 - europepmc.org
Background and purpose Roscovitine, a cyclin-dependent kinase (CDK) inhibitor that
induces tumour cell death, is under evaluation as an anti-cancer drug. By triggering …
induces tumour cell death, is under evaluation as an anti-cancer drug. By triggering …